195 related articles for article (PubMed ID: 37481637)
1. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
2. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
Chapman BV; Wald AI; Akhtar P; Munko AC; Xu J; Gibson SP; Grandis JR; Ferris RL; Khan SA
BMC Cancer; 2015 Nov; 15():861. PubMed ID: 26545583
[TBL] [Abstract][Full Text] [Related]
5. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment.
Ding Q; Lin F; Huang Z; Li Y; Cai S; Chen X; Liu H; Qiu S
Sci Rep; 2024 Feb; 14(1):4426. PubMed ID: 38396056
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA
Jiang Y; Wu K; Cao W; Xu Q; Wang X; Qin X; Wang X; Li Y; Zhang J; Chen W
Epigenomics; 2020 Mar; 12(6):487-505. PubMed ID: 32267161
[No Abstract] [Full Text] [Related]
8. Immune Infiltration-Related ceRNA Network Revealing Potential Biomarkers for Prognosis of Head and Neck Squamous Cell Carcinoma.
Zhao S; Peng M; Wang Z; Cao J; Zhang X; Yu R; Huang T; Lian W
Dis Markers; 2022; 2022():1014347. PubMed ID: 36097539
[TBL] [Abstract][Full Text] [Related]
9. Spermine synthase (
Pan X; Xue L; Sun Y
Ann Transl Med; 2022 Nov; 10(22):1213. PubMed ID: 36544695
[TBL] [Abstract][Full Text] [Related]
10. Biomarker Potential of
Ju Y; Zhu F; Fang B
Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
[TBL] [Abstract][Full Text] [Related]
11. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
Huang J; Liang B; Wang T
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
[TBL] [Abstract][Full Text] [Related]
12. Non-coding RNA-mediated high expression of
Chen K; Gong S; Fang X; Li Q; Ye M; Li J; Huang S; Zhao Y; Liu N; Li Y; Ma J
Front Immunol; 2022; 13():920136. PubMed ID: 36159813
[TBL] [Abstract][Full Text] [Related]
13. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
[TBL] [Abstract][Full Text] [Related]
14. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma.
Li SH; Qian L; Chen YH; Lu HI; Tsai HT; Lyu H; Yang R; Chen CH
J Cell Physiol; 2022 Sep; 237(9):3671-3686. PubMed ID: 35861939
[TBL] [Abstract][Full Text] [Related]
15. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TM4SF19-AS1 exacerbates cell proliferation, migration, invasion, and EMT in head and neck squamous cell carcinoma via enhancing LAMC1 expression.
Yu Z; Wang X; Niu K; Sun L; Li D
Cancer Biol Ther; 2022 Dec; 23(1):1-9. PubMed ID: 36411963
[TBL] [Abstract][Full Text] [Related]
17. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression.
Ma Y; Han J; Luo X
Oral Dis; 2023 Mar; 29(2):604-614. PubMed ID: 34403535
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma.
Hu R; Lu M; She L
Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444
[TBL] [Abstract][Full Text] [Related]
19. The impact of LncRNA-SOX2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
Wang D; Zhao X; Li S; Guo H; Li S; Yu D
Cell Signal; 2024 Mar; 115():111018. PubMed ID: 38110167
[TBL] [Abstract][Full Text] [Related]
20. lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis.
Fan J; Wang C; Zhai X; Li J; Ju J; Zhu Y; Zheng S; Ren N; Huang B; Jiang X; Xie Y; Zhao K; Liu M
Dis Markers; 2022; 2022():3881310. PubMed ID: 35371339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
